Chinese biotech firm Adagene plans $200m US IPO

Chinese biotech firm Adagene plans $200m US IPO

Adagene is a clinical stage oncology-based biotech company

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter